Ilex Medical Ltd (TLV:ILX)
Israel · Delayed Price · Currency is ILS · Price in ILA 6,000.00
-409.00 (-6.38%)
Feb 5, 2026, 5:27 PM IDT
Ilex Medical Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 43.64 | 38.98 | 50.89 | 102.12 | 197.48 | 120.62 |
Depreciation & Amortization | 48.38 | 47.46 | 46.53 | 50.04 | 50.49 | 39.89 |
Other Amortization | 1.64 | 1.64 | 1.2 | - | - | - |
Loss (Gain) From Sale of Assets | 0.17 | 0.46 | -0.26 | -21.96 | 0.01 | 0.36 |
Loss (Gain) From Sale of Investments | -0.36 | -3.47 | -4.12 | 2.84 | -3.68 | 0.71 |
Loss (Gain) on Equity Investments | 8.38 | 7.19 | 4.01 | 2.69 | 0.26 | - |
Other Operating Activities | 15.57 | 12.51 | -10.89 | -24.42 | 25.16 | 2.55 |
Change in Accounts Receivable | 34.29 | 32.14 | -56 | -23.9 | 21.28 | -26.24 |
Change in Inventory | -32.15 | -0.22 | -14.13 | -27.71 | 20.89 | -47.87 |
Change in Accounts Payable | 4.19 | -43.96 | 32.49 | 10.6 | -20.22 | 46.93 |
Change in Unearned Revenue | -61.59 | 3.77 | 96.58 | - | - | - |
Change in Other Net Operating Assets | 49.16 | -8.16 | -61.21 | 5.79 | -21 | 45.44 |
Operating Cash Flow | 110.28 | 81.63 | 80.43 | 69.74 | 270.68 | 182.4 |
Operating Cash Flow Growth | -3.16% | 1.49% | 15.33% | -74.23% | 48.39% | 114.88% |
Capital Expenditures | -24.65 | -29.76 | -48.77 | -26.14 | -40.94 | -44.3 |
Sale of Property, Plant & Equipment | 0.01 | 0.28 | 0.17 | 0.08 | 1.06 | 0.02 |
Cash Acquisitions | - | - | - | -10.51 | - | - |
Divestitures | 1.94 | 1.94 | - | - | - | - |
Sale (Purchase) of Intangibles | -3.8 | -3.58 | -3.39 | -2.22 | -1.7 | -2.08 |
Sale (Purchase) of Real Estate | - | - | - | 43 | - | - |
Investment in Securities | -18.67 | 8.18 | -38.68 | -50.78 | -38.1 | 21.66 |
Other Investing Activities | -23.56 | - | - | -7.07 | -2.78 | - |
Investing Cash Flow | -68.73 | -22.94 | -90.68 | -53.64 | -82.45 | -24.71 |
Short-Term Debt Repaid | - | - | - | - | -0.22 | -15.74 |
Long-Term Debt Repaid | - | -13.63 | -13.56 | -13.71 | -26.56 | -29.52 |
Total Debt Repaid | -13.74 | -13.63 | -13.56 | -13.71 | -26.77 | -45.26 |
Net Debt Issued (Repaid) | -13.74 | -13.63 | -13.56 | -13.71 | -26.77 | -45.26 |
Repurchase of Common Stock | - | - | -5.72 | -3.49 | - | - |
Common Dividends Paid | -13.64 | -15.27 | -21.44 | -60 | -60 | - |
Other Financing Activities | - | - | - | -0.1 | -0.01 | -3.48 |
Financing Cash Flow | -27.39 | -28.89 | -40.72 | -77.3 | -86.78 | -48.74 |
Foreign Exchange Rate Adjustments | -1.21 | -0.93 | -1.61 | 2.92 | -2.04 | 0.45 |
Net Cash Flow | 12.95 | 28.87 | -52.57 | -58.28 | 99.41 | 109.41 |
Free Cash Flow | 85.63 | 51.87 | 31.66 | 43.6 | 229.73 | 138.1 |
Free Cash Flow Growth | 3.36% | 63.83% | -27.38% | -81.02% | 66.35% | 151.20% |
Free Cash Flow Margin | 9.34% | 5.64% | 3.46% | 5.05% | 21.65% | 14.59% |
Free Cash Flow Per Share | 7.66 | 4.64 | 2.83 | 3.87 | 20.36 | 12.94 |
Cash Interest Paid | 2.52 | 2.35 | 1.8 | 1.61 | 1.93 | 2.09 |
Cash Income Tax Paid | 2.74 | 14.04 | 34.31 | 76.77 | 30.79 | 28.53 |
Levered Free Cash Flow | 72.32 | 29.62 | 36.78 | 35.97 | 168.57 | 110.9 |
Unlevered Free Cash Flow | 73.85 | 31.08 | 37.89 | 36.95 | 169.8 | 112.36 |
Change in Working Capital | -6.1 | -16.43 | -2.28 | -35.22 | 0.95 | 18.27 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.